|
The surgical issue questionnaire was reviewed for potential causes of the reported issue.Based on this review, implanting the device after the expiration date, not prepping the surface of the skin with an antiseptic solution, not irrigating the incision site with an antibiotic solution before closure, improperly closing the surgical site, multiple tunneling attempts, using incorrect tools, and not prescribing antibiotics pre-operatively have been ruled out.Additionally, the patient picking or touching the wound, implanting the device off-label and the patient having contraindicating conditions have been ruled out as potential causes.A curonix representative conducted a review of sterilization and packaging records for the respective product lot; curonix has confirmed that the product was delivered sterile, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.The stimulator is used to treat pain.The cause of the redness and drainage is unknown.The investigation findings do not lead to a clear conclusion about the cause of the reported issue.Therefore, conclusion has been selected as unable to determine root cause.Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in surgical issues.Surgical issue rates remain acceptably low; thus, a capa is not required at this time.Surgical issue rates will continue to be tracked and trended.
|
|
The patient reported redness and some drainage at the receiver site.However, there was no odor reported.The patient had limited use of neurostimulator, per the implanting clinician, following the post-op visit to allow for healing.On (b)(6) 2025, the patient slowly began to increase usage of the device.As of (b)(6) 2026, the wound is healing, the patient is receiving therapy, and the incisions were not infected.
|